SCHEMBL13437204

SCHEMBL13437204

O=C(NC1c2ccccc2-c2c(-c3nc4ccncc4[nH]3)cccc21)c1ccnc(F)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 5/20 0.81
PDE5A O76074 3/20 0.39
HDAC6 Q9UBN7 4/20 0.38
HDAC3 O15379 2/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC10 Q969S8 1/20 0.38
APLNR P35414 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
TAS1R2 Q8TE23 1/20 0.37
METAP2 P50579 1/20 0.37
METAP1 P53582 1/20 0.37
IRAK4 Q9NWZ3 1/20 0.37
BACE1 P56817 1/20 0.37
HPSE Q9Y251 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12430902 0.90 HSP90AB1 (0.79) HSP90AB1PDE5AHDAC6HDAC3HDAC7
SCHEMBL12430429 0.90 HSP90AB1 (1.00) HSP90AB1PDE5AHDAC6HDAC3HDAC7
SCHEMBL13437201 0.90 HSP90AB1 (0.81) HSP90AB1PDE5AHDAC6HDAC3HDAC7
SCHEMBL13437209 0.90 HSP90AB1 (0.81) HSP90AB1PDE5AHDAC6HDAC3HDAC7
SCHEMBL13437166 0.89 HSP90AB1 (1.00) HSP90AB1PDE5AAPLNRMETAP2METAP1
SCHEMBL13437193 0.89 HSP90AB1 (0.78) HSP90AB1PDE5AHDAC6HDAC3HDAC7
SCHEMBL12430624 0.89 HSP90AB1 (0.80) HSP90AB1PDE5AHDAC6HDAC3HDAC7
SCHEMBL13437214 0.88 HSP90AB1 (0.79) HSP90AB1PDE5AHDAC6HDAC3HDAC7
SCHEMBL12431609 0.87 HSP90AB1 (0.79) HSP90AB1PDE5AHDAC6HDAC3HDAC7
SCHEMBL13437210 0.87 HSP90AB1 (0.78) HSP90AB1PDE5AHDAC6HDAC3HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof HSP90B1, HSP90AB1, HSP90AA1 HSP90AB1 2/4885PDE5A 2779/4885HDAC6 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.